Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy
Hinson J.T. Chopra A. Nafissi N. Polacheck W.J. Benson C.C. Swist S. Gorham J. Yang L. Schafer S. Sheng C.C.
Hinson J.T.
Chopra A.
Nafissi N.
Polacheck W.J.
Benson C.C.
Swist S.
Gorham J.
Yang L.
Sheng C.C.
Citations
Altmetric:
Alternative Title
Abstract
Human mutations that truncate the massive sarcomere protein titin [TTN-truncating variants (TTNtvs)] are the most common genetic cause for dilated cardiomyopathy (DCM), a major cause of heart failure and premature death. Here we show that cardiac microtissues engineered from human induced pluripotent stem (iPS) cells are a powerful system for evaluating the pathogenicity of titin gene variants. We found that certain missense mutations, like TTNtvs, diminish contractile performance and are pathogenic. By combining functional analyses with RNA sequencing, we explain why truncations in the A-band domain of TTN cause DCM, whereas truncations in the I band are better tolerated. Finally, we demonstrate that mutant titin protein in iPS cell-derived cardiomyocytes results in sarcomere insufficiency, impaired responses to mechanical and ?-adrenergic stress, and attenuated growth factor and cell signaling activation. Our findings indicate that titin mutations cause DCM by disrupting critical linkages between sarcomerogenesis and adaptive remodeling.
Keywords
Source Title
Science
Publisher
American Association for the Advancement of Science
Series/Report No.
Collections
Rights
Date
2015
DOI
10.1126/science.aaa5458
Type
Article